Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 5 of 5 for “"dual antiplatelet therapy"”.

  1. The Effect of Tranexamic Acid on Transfusion Requirement in Dual Antiplatelet-Treated Anemic Patients Undergoing Off-Pump Coronary Artery Bypass Graft Surgery

    … (CABG). As these patients are frequently on dual antiplatelet therapy, the two coexisting conditions could potentially increase the risk of bleeding and transfusion. The aim of this study was to evaluate the effect of tranexamic acid (TA) on blood loss and transfusion in preoperatively anemic …

    ajou Repository record for The Effect of Tranexamic Acid on Transfusion Requirement in Dual Antiplatelet-Treated Anemic Patients Undergoing Off-Pump Coronary Artery Bypass Graft Surgery (opens in a new tab)

  2. Clinical outcome and Predictive factors of Coronary aneurysm after Percutaneous Coronary Intervention

    … favorable clinical courses with continuous dual-antiplatelet therapy (Ahn et al., 2010) although poor clinical outcomes including in-stent restenosis and stent thrombosis after drug-eluting stent (DES) implantation were increased with CAAs after DES implantation (James et al., 2009). In this …

    ajou Repository record for Clinical outcome and Predictive factors of Coronary aneurysm after Percutaneous Coronary Intervention (opens in a new tab)

  3. Comparing long-term antiplatelet strategies to prevent morbidity and mortality in patients with drug-eluting coronary stents

    Background: The optimal long-term antiplatelet therapy (APT) that balances the benefit of preventing myocardial infarction (MI) with the risk of severe bleeding is unknown in patients greater than one year after drug-eluting stent (DES) placement. Methods: We modeled life expectancy (LE) using …

    mit Repository record for Comparing long-term antiplatelet strategies to prevent morbidity and mortality in patients with drug-eluting coronary stents (opens in a new tab)

  4. Development and experimental validation of a novel arterial thrombosis-on-a-chip microfluidic device

    … ‘off-site’ activity can mask the efficacy of antiplatelet compounds, but these erroneous effects were removed by the addition of downstream EDTA-solution. I then showed that the EDTA-quenched design is sensitive to differences in concentration of eptifibatide, further supporting it as an …

    cambridge Repository record for Development and experimental validation of a novel arterial thrombosis-on-a-chip microfluidic device (opens in a new tab)